UNSPSC 51162307: Acetaminophen/caffeine/guaifenesin/phenylephrine
Commodity
Code facts
- Part of
-
-
51000000
-
51160000
- 51162300
-
51160000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51162307
Definition
This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.
The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.
Read the full definition
The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification.
The second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula C8H10N4O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3G6A5W338E, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears U.S. National Institutes of Health Compound Identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate.
The European Medicines Agency schedules Caffeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13146MIG. The third component of this combination drug is an expectorant with the molecular formula C10H14O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 495W7451VQ, chemically known as 1,2,3-propanetriol, ether with 2-methoxyphenol but more generally known as guaifenesin, which bears U.S. National Institutes of Health Compound Identifier 3516.
The European Medicines Agency schedules Guaifenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07973MIG. The term GUAIFENESIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25, No. 10 1971, List 11). The World Health Organization schedules guaifenesin in its Anatomical Therapeutic Chemical (ATC) Classification.
The fourth component of this combination drug is an alpha-adrenergic agonist with the molecular formula C9H13NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 1WS297W6MV, chemically known as tannins, compds. with (r)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol but more generally known as phenylephrine, which bears U.S. National Institutes of Health Compound Identifier 6041. The European Medicines Agency schedules Phenylephrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09788MIG.
The term PHENYLEPHRINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, No. 10 1976, List 16). The World Health Organization schedules phenylephrine in its Anatomical Therapeutic Chemical (ATC) Classification.
About UNSPSC 51162307
UNSPSC 51162307 Acetaminophen/caffeine/guaifenesin/phenylephrine is a Commodity code that in recent state and local solicitations covers parenteral pharmaceutical products and medical supplies delivered to correctional and public health facilities. The Washington State Department of Corrections' RFQQ RFQQK13020 (due October 7, 2026) solicits parenteral nutrition solutions, intravenous solutions, and controlled substances for eight correctional facilities across the state, with bidders required to demonstrate documented experience preparing and delivering IV solutions and adjusting nutritional preparations within strict turnaround windows (24 hours for PN bags, 8 hours for other parenteral products). Issuing bodies under this code include state correction departments and county health authorities; the source shows activity from a state DOC and a county health initiative, with the state correctional buyer setting qualification bars including Washington State business licensure, successful Washington State Patrol NCIC clearance for all service personnel, and specified commercial general liability ($1 million per occurrence/$2 million aggregate), professional liability ($2 million per occurrence/aggregate), business automobile liability ($1 million per occurrence/$2 million aggregate), and cyber liability ($2 million per occurrence/aggregate) insurance.
Activity concentrates in Washington and Florida. The Washington State Department of Corrections RFQQ anticipates selecting up to three contractors per region across West, Central, and East zones, with an initial contract term running November 26, 2026 through June 30, 2030 and fixed pricing for the first two years. Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026) procures 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, though the due date shown (July 26, 2023) predates the posting date and may reflect a data error. The Washington solicitation actively encourages participation from small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%) certified through appropriate state agencies and requires a Subcontractor Inclusion Plan identifying qualified minority-owned, women-owned, and disadvantaged subcontractors where feasible.
Quick answers
What is UNSPSC 51162307?
UNSPSC 51162307 is Acetaminophen/
Which NIGP codes match UNSPSC 51162307?
UNSPSC 51162307 maps to 1 NIGP code, 26948 Expectorants, Antitussives, and Mucolytic Agents.
On GovTribe
See everything under UNSPSC 51162307
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code